Advertisements



We are Sorry, This Page doesn't Exist


AbbVie: FDA lifts partial clinical hold on Phase 3 study of venetoclax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 24th, 2019

Celgene announces updated analysis of data from Phase 2 JAKARTA2 clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2019

Advaxis says FDA lifts partial clinical hold on Phase 3 AIM2CERV study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Xencor says FDA lifts partial clinical hold on Phase 1 study of XmAb14045

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 30th, 2019

Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

Xencor announces partial clinical hold on Phase 1 study of XmAb14045

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2019

Celsion says Phase III OPTIMA study on track for interim data analysis in July

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2020

Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update

Dosed First Patient in Phase 1/2a Clinical Study of PBCAR20A in R.....»»

Category: earningsSource: benzingaMay 15th, 2020

I-MAB says first patient dosed in Phase 1/2 clinical study of CD73 antibody TJD5

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2020

Gamida Cell says Phase 3 clinical study of omidubicel met primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2020

Bellerophon announces FDA clearance for initiation of Phase 3 study for INOpulse

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 11th, 2020

Solid Biosciences says SGT-001 Phase I/II trial remains on clinical hold

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2020

DelMar enrolled 22 patients in arm of Phase 2 clinical study with VAL-083

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 5th, 2020

Annovis Bio to proceed with Phase 2 clinical study in PD and AD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 30th, 2020

BeyondSpring Reports Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update

- FDA Submission to Change the Primary Endpoint for Study 106 Phase 3 into an Industry First and Robust Clinical Measure to Evaluate Superiority in CIN - - Initiated NDA Rolling Submission for Plinabulin for CIN in China in Q1 2020 - - On Track.....»»

Category: earningsSource: benzingaApr 30th, 2020

Recce Pharmaceuticals Announces First-Quarter 2020 Financial Results and Provides Operational Highlights

Highlights: Strong cash position with reserves of AUD $4.09M Formalized a Phase I Clinical trial agreement to conduct a first-in-human study of RECCE® 327 Completed successful in-vivo toxicity st.....»»

Category: earningsSource: benzingaApr 29th, 2020

Apellis reports analysis from Phase 1b geographic atrophy study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 28th, 2020

Verastem announces preliminary data from VS-6766 Phase 1 clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 27th, 2020

Celsion reports sufficient events reached in analysis of Phase III OPTIMA study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2020

Potential coronavirus drugs may cost as little as $1, study says

Potential coronavirus treatments could be made for as little as $1, well below their typical price tags in pharmacies, according to an analysis of nine drugs in clinical trials. If their promise is... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkApr 15th, 2020